Market Research Report
North American Hyaluronic Acid-Based Dermal Fillers Market 2019-2025
|Published by||Orion Market Research Pvt Ltd||Product code||925697|
Delivery time: 2-3 business days
|North American Hyaluronic Acid-Based Dermal Fillers Market 2019-2025|
|Published: January 15, 2020||Content info:||
North American Hyaluronic Acid-Based Dermal Fillers Market Size, Share & Trends Analysis Report by Application (Face-Lift, Lip Treatment/Enhancement, Facial Line Correction Treatment, and Others), by Type (Collagen Fillers, Poly-L-Lactic Acid, Hyaluronic Acid, Calcium Hydroxyapatite, and Others), and by End-User (Dermatology Hospital and Clinics), and Forecast 2019-2025.
The North American hyaluronic acid-based dermal fillers market is estimated to grow at a CAGR of 7.3% during the forecast period. The North American market is expected to reach around $2.4 billion in 2025 as compared to nearly $1.4 billion in 2018. Growing minimally invasive procedures has increased the number of cosmetic procedures in the region as the minimally invasive procedure provides faster recovery and better cosmetic results which are contributing to the market growth. Other crucial factors are promoting market growth in the region. This includes a significant rise in the population with the age group, ranging between 18 and 64. For instance, as per the US Census Bureau, in 2017, the total population in the US was 325.7 million, of which 62% was constituted by 18-64 age group people. This, in turn, is contributing to the demand for advanced dermal fillers in the region coupled with increasing consciousness about physical appearance.
The main objective of dermal filler is to replace the lost volume that causes the cheeks to flatten, marionette lines to form and develop nasolabial folds. The procedure is intended to correct this loss of volume in a natural, subtle way and restore volume to the face. To improve the efficiency of the treatment, the US FDA has approved multiple dermal fillers which are produced from temporary or absorbable material for the correction of moderate to severe facial wrinkles and skin folds, including nasolabial folds. It has approved dermal filler produced from non-absorbable (permanent) material only for the correction of cheek acne scars and nasolabial folds in patients more than the age of 21 years. The North American hyaluronic acid-based dermal fillers market is segmented based on application, type, and end-users. Based on application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other applications. Based on end-user, the market is segmented into dermatology clinics and hospitals.
Key players operating in the North American hyaluronic acid-based dermal fillers market include Allergan PLC, Galderma Laboratories, L.P., Merz Pharmaceuticals GmbH, Cynosure LLC, Prollenium Medical Technologies, Inc., and Teoxane SA. These companies adopt various strategies such as partnership & collaborations, finding a new market or product innovations in their core competency in order to stay competitive in the market. For instance, in November 2018, Galderma Laboratories, L.P. received an FDA approval for 'Restylane Lyft', a hyaluronic acid dermal filler used for cheek augmentation and age-related face contour deficiencies.
The market study of the North American hyaluronic acid-based dermal fillers market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
The report is intended for healthcare companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.